Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza ? ER and Other ER Opioid Formulations

Stephen P. Mayock; Said Saim; Alison B. Fleming

首页> 外文期刊>Clinical drug investigation >Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza ? ER and Other ER Opioid Formulations

【24h】

Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza ? ER and Other ER Opioid Formulations

机译：作者矫正：破碎后体外药物释放：Xtampza的评价？ ER和其他ER表阿片类配方

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Abstract Following correction should be noted.

机译：摘要应注意以下更正。

著录项

来源
《Clinical drug investigation》 |2017年第12期|共1页
作者
Stephen P. Mayock; Said Saim; Alison B. Fleming;
展开▼
作者单位

Collegium Pharmaceutical Inc.;

Collegium Pharmaceutical Inc.;

Collegium Pharmaceutical Inc.;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza ? ER and Other ER Opioid Formulations [J] . Stephen P. Mayock, Said Saim, Alison B. Fleming Clinical drug investigation . 2017,第12期

机译：作者矫正：破碎后体外药物释放：Xtampza的评价？ ER和其他ER表阿片类配方
2. Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza (R) ER and Other ER Opioid Formulations [J] . Crudele Nancy, Giordano Jennifer Clinical drug investigation . 2018,第8期

机译：评论Mayock SP，Saim S，Fleming AB。破碎后的体外药物释放：Xtampza（R）ER和其他ER阿片类药物的评价
3. In Vitro Drug Release After Crushing: Evaluation of Xtampza ? ER and Other ER Opioid Formulations [J] . Stephen P. Mayock, Said Saim, Alison B. Fleming Clinical drug investigation . 2017,第12期

机译：破碎后的体外药物释放：Xtampza的评价？ ER和其他ER表阿片类配方
4. Evaluation of the effect of polymer content on drug release and mechanical strength of a Geopolymer ER Formulation for opioid drugs [C] . Bing Cai, Hakan Engqvist, Susanne Bredenberg European conference on biomaterials . 2014

机译：评估聚合物含量对阿片类药物地聚物ER配方的药物释放和机械强度的影响
5. 1. Evaluation of polycarbophil coated liposomes and membrane permeation of free and liposomal drugs, 2. In vitro-in vivo evaluation of nicardipine HCl sustained-release formulations [D] . Sorasuchart, Waranush. 1998

机译：1.评估聚卡波非包衣的脂质体和游离药物和脂质体药物的膜渗透性，2.尼卡地平HCl缓释制剂的体外-体内评估
6. Comment on Mayock SP Saim S Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations [O] . Nancy Crudele, Jennifer Giordano -1

机译：评论Mayock SPSaim SFleming AB。压碎后的体外药物释放：Xtampza®ER和其他ER阿片类药物制剂的评估
7. Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations [O] . Stephen P. Mayock, Said Saim, Alison B. Fleming 2017

机译：作者矫正：破碎后的体外药物释放：评估XTampza®ER和其他ER阿片类药物的制剂
8. LUMI-CELL (Trade Name) ER (BG1Luc ER TA) Test Method: An In Vitro Assay for Identifying Human Estrogen Receptor Agonist and Antagonist Activity of Chemicals. ICCVAM Test Method Evaluation Report. [R] . 2015

机译：LUmI-CELL（商品名）ER（BG1Luc ER Ta）测试方法：用于鉴定人类雌激素受体激动剂和化学品拮抗剂活性的体外测定。 ICCVam测试方法评估报告。

Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza ? ER and Other ER Opioid Formulations

摘要

著录项

相似文献

相关主题

期刊订阅